BCRX

#1835
BioCryst Pharmaceuticals Inc
9.67 USD
+2.65%
版块: 医疗保健
基础: USD
利润货币: USD
日范围
9.67
9.67
年范围
6.00
11.31
日变化
+2.65%
每月变动
+17.64%
6个月变化
+48.31%
年变化
+38.34%
前一天收盘价
9.42
开盘价
9.67
买价
卖价
最低价
9.67
High
9.67
交易量
103
展开完整图表

Financials

概览 声明 统计
每季度 年度
  • Market Capitalization 2.43 B
  • Employee 435
  • Founded 1986
  • CEO Jon P. Stonehouse
  • Website www.biocryst.com
  • Headquarter Delaware, United States
  • FIGI BBG000BLYWX6
  • Industry Technology
总收入
净利润
每股基本收益（基本 EPS）
总债务
自由现金流
现金及现金等价物
市盈率
6.45
市销率
1.95

BioCryst Pharmaceuticals Inc

BioCryst Pharmaceuticals, Inc. is an American pharmaceutical company headquartered in Durham, North Carolina. The company is a late stage biotech company that focuses on oral drugs for rare and serious diseases. BioCryst's antiviral drug peramivir was approved by FDA in December 2014. It has also been approved in Japan, Korea, and China.

新闻